Johnson & Johnson (JNJ) stock
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3083% above fair value
$272.70−6.00 (-2.15%)
Close on Nov 18, 2026Market cap $656.47BP/E 41.4Yield 1.88%
Johnson & Johnson price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Johnson & Johnson's price to sales ratio was 6.9× on Nov 11, 2026, against 5.4× a year earlier. Over the last 5 years it ranged from 4.0× to 6.9×, with a median of 5.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 6.9× | +1.5 |
| 2025 | Dec 31, 2025 | 5.4× | +1.4 |
| 2024 | Dec 31, 2024 | 4.0× | −0.9 |
| 2023 | Dec 29, 2023 | 4.9× | −1.9 |
| 2022 | Dec 30, 2022 | 6.7× | +1.7 |
| 2021 | Dec 31, 2021 | 5.0× | −0.2 |
| 2020 | Dec 31, 2020 | 5.2× | +0.4 |
| 2019 | Dec 31, 2019 | 4.8× | +0.5 |
| 2018 | Dec 31, 2018 | 4.3× | −0.8 |
| 2017 | Dec 29, 2017 | 5.2× | +0.7 |
| 2016 | Dec 30, 2016 | 4.5× | +0.4 |
| 2015 | Dec 31, 2015 | 4.1× | +0.1 |
| 2014 | Dec 31, 2014 | 4.0× | +0.3 |
| 2013 | Dec 31, 2013 | 3.7× | +0.8 |
| 2012 | Dec 31, 2012 | 3.0× | −0.0 |
| 2011 | Dec 30, 2011 | 3.0× | +0.2 |
| 2010 | Dec 31, 2010 | 2.8× | −0.2 |
| 2009 | Dec 31, 2009 | 3.0× | – |
See a number that looks wrong?